Jane Street
OMGA

Jane Street’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Jane Street’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-213,497
Closed -$442K – 10616
2024
Q2 		$442K Buy
+213,497
New +$503K ﹤0.01% 7216
2024
Q1 		– Sell
-31,261
Closed -$94.1K – 10269
2023
Q4 		$94.1K Buy
+31,261
New +$63.4K ﹤0.01% 8606
2023
Q2 		– Sell
-92,145
Closed -$556K – 9758
2023
Q1 		$556K Buy
+92,145
New +$642K ﹤0.01% 6151
2022
Q1 		– Sell
-17,927
Closed -$203K – 11176
2021
Q4 		$203K Buy
+17,927
New +$341K ﹤0.01% 8804

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's OMGA Position: Q3 2024 in Review

Jane Street sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2024, closing a stake of 213,497 shares — an estimated $442K sold.

Jane Street first reported a position in OMGA in Q4 2021 and held it in 4 quarters. The position peaked at $556K in Q1 2023. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

  • Jane Street reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Jane Street sold 213,497 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $442K.
  • Jane Street first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Jane Street's Omega Therapeutics, Inc. Common Stock position peaked at $556K in Q1 2023.
  • 54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.